| Comprehensive and integrative genomic characterization of hepatocellular carcinoma A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ... Cell 169 (7), 1327-1341. e23, 2017 | 1845 | 2017 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1559 | 2018 |
| A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression RH Wang, C Li, X Xu, Y Zheng, C Xiao, P Zerfas, S Cooperman, ... Cell metabolism 2 (6), 399-409, 2005 | 779 | 2005 |
| The role of TGF-β/SMAD4 signaling in cancer M Zhao, L Mishra, CX Deng International journal of biological sciences 14 (2), 111, 2018 | 530 | 2018 |
| EMT, CTCs and CSCs in tumor relapse and drug-resistance A Mitra, L Mishra, S Li Oncotarget 6 (13), 10697, 2015 | 503 | 2015 |
| Comparative molecular analysis of gastrointestinal adenocarcinomas Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, ... Cancer cell 33 (4), 721-735. e8, 2018 | 478 | 2018 |
| Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications CR Churi, R Shroff, Y Wang, A Rashid, HSC Kang, J Weatherly, M Zuo, ... PloS one 9 (12), e115383, 2014 | 447 | 2014 |
| Liver stem cells and hepatocellular carcinoma L Mishra, T Banker, J Murray, S Byers, A Thenappan, AR He, K Shetty, ... Hepatology 49 (1), 318-329, 2009 | 406 | 2009 |
| Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling Y Tang, K Kitisin, W Jogunoori, C Li, CX Deng, SC Mueller, HW Ressom, ... Proceedings of the National Academy of Sciences 105 (7), 2445-2450, 2008 | 386 | 2008 |
| Disruption of transforming growth factor-β signaling in ELF β-spectrin-deficient mice Y Tang, V Katuri, A Dillner, B Mishra, CX Deng, L Mishra Science 299 (5606), 574-577, 2003 | 328 | 2003 |
| Targeting TGF-β signaling in cancer LH Katz, Y Li, JS Chen, NM Muñoz, A Majumdar, J Chen, L Mishra Expert opinion on therapeutic targets 17 (7), 743-760, 2013 | 260 | 2013 |
| The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling L Lin, R Amin, GI Gallicano, E Glasgow, W Jogunoori, JM Jessup, ... Oncogene 28 (7), 961-972, 2009 | 257 | 2009 |
| TGF-β signaling in development K Kitisin, T Saha, T Blake, N Golestaneh, M Deng, C Kim, Y Tang, ... Science's STKE 2007 (399), cm1-cm1, 2007 | 256 | 2007 |
| Transforming growth factor-β signaling in stem cells and cancer L Mishra, R Derynck, B Mishra Science 310 (5745), 68-71, 2005 | 245 | 2005 |
| HER2/neu-directed therapy for biliary tract cancer M Javle, C Churi, HSC Kang, R Shroff, F Janku, R Surapaneni, M Zuo, ... Journal of hematology & oncology 8, 1-9, 2015 | 234 | 2015 |
| Technologies for deriving primary tumor cells for use in personalized cancer therapy A Mitra, L Mishra, S Li Trends in biotechnology 31 (6), 347-354, 2013 | 234 | 2013 |
| The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer L Mishra, K Shetty, Y Tang, A Stuart, SW Byers Oncogene 24 (37), 5775-5789, 2005 | 218 | 2005 |
| Transforming growth factor-β and wound healing BJ Faler, RA Macsata, D Plummer, L Mishra, AN Sidawy Perspectives in vascular surgery and endovascular therapy 18 (1), 55-62, 2006 | 212 | 2006 |
| Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on β1-integrin to promote normal liver development M Weinstein, SPS Monga, Y Liu, SG Brodie, Y Tang, C Li, L Mishra, ... Molecular and cellular biology, 2001 | 194 | 2001 |
| Baseline human gut microbiota profile in healthy people and standard reporting template CH King, H Desai, AC Sylvetsky, J LoTempio, S Ayanyan, J Carrie, ... PloS one 14 (9), e0206484, 2019 | 186 | 2019 |
